Skip to main content
Equibles
INSP logo

INSP · Inspire Medical Systems, Inc.

Track INSP — free

Use INSP with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about INSP

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$57.10 -1.10 (-1.89%) At close · Aug 14
Market Cap
$1.65B
Shares
28.91M

Inspire Medical Systems, Inc. Earnings Call Transcripts

Every quarterly earnings call for Inspire Medical Systems, Inc. (INSP) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲77% $109.19M −$16.85M '22 Q3 22-11-01 ▲75.9% $137.90M $3.15M '22 Q4 23-02-07 ▲84.3% $127.90M −$15.42M '23 Q1 23-05-02 ▲65.3% $151.09M −$11.95M '23 Q2 23-08-01 ▲40.4% $153.30M −$8.54M '23 Q3 23-11-07 ▲39.6% $192.51M $14.76M '23 Q4 24-02-06 ▲28.2% $164.01M −$10.01M '24 Q1 24-05-07 ▲29.6% $195.88M $9.79M '24 Q2 24-08-06 ▲32.5% $203.19M $18.50M '24 Q3 24-11-04 ▲24.5% $239.72M $35.22M '24 Q4 25-02-10 ▲22.7% $201.32M $2.99M '25 Q1 25-05-05 ▲10.8% $217.09M −$3.59M '25 Q2 25-08-04 ▲10.5% $224.50M $9.93M '25 Q3 25-11-03 ▲12.2% $269.08M $136.09M '25 Q4 26-02-11 ▲1.6% $204.58M −$11.29M '26 Q1 26-05-04 LATEST ▼7.6% $200.58M $314,000 '26 Q2 26-08-03
Earnings call
FY26 · Q2
2026-08-03
Q2 2026 Earnings Webcast
Revenue
$200.58M
▼ 7.6% YoY
Diluted EPS
$0.01
Gross margin
85.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-04
Inspire Medical Systems, Inc. Q1 FY2026 Earnings Call
Cautious tone Coding and reimbursement challenges for Inspire V WISER government prior authorization program Long-term CPT code path effective 2028
Revenue
$204.58M
▲ 1.6% YoY
Diluted EPS
$-0.39
▼ 490% YoY
Gross margin
86.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-11
Inspire Medical Systems, Inc. Q4 FY2025 Earnings Call
Cautious tone Inspire 5 coding and reimbursement Inspire 5 launch and clinical performance WISER prior authorization program
Revenue
$269.08M*
▲ 12.2% YoY
Gross margin
86.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-03
Inspire Medical Systems, Inc. Q3 FY2025 Earnings Call
Confident tone Inspire V Launch and Adoption Revenue and Earnings Guidance GLP-1 Drugs and Patient Funnel
Revenue
$224.50M
▲ 10.5% YoY
Diluted EPS
$0.34
▼ 43.3% YoY
Gross margin
85.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-04
Inspire Medical Systems, Inc. Q2 FY2025 Earnings Call
Cautious tone Inspire V Commercial Rollout Challenges Revised Full Year 2025 Guidance CPT Code 64568 / Medicare Reimbursement
Revenue
$217.09M
▲ 10.8% YoY
Diluted EPS
$-0.12
▼ 137.5% YoY
Gross margin
84.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-05
Inspire Medical Systems, Inc. Q1 FY2025 Earnings Call
Confident tone Inspire V full launch International expansion Medical education and provider capacity
Revenue
$201.32M
▲ 22.7% YoY
Diluted EPS
$0.10
Gross margin
84.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-10
Inspire Medical Systems, Inc. Q4 FY2024 Earnings Call
Confident tone Inspire V product launch and ramp Financial performance and 2025 guidance Medical education and provider training
Revenue
$239.72M*
▲ 24.5% YoY
Gross margin
85.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-04
Inspire Medical Systems, Inc. Q3 FY2024 Earnings Call
Confident tone Inspire V product launch Revenue growth and guidance raise SleepSync and digital initiatives
Revenue
$203.19M
▲ 32.5% YoY
Diluted EPS
$0.60
Gross margin
84.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Inspire Medical Systems, Inc. Q2 FY2024 Earnings Call
Confident tone Revenue growth and guidance raise EU MDR certification and France reimbursement U.S. commercial expansion
Revenue
$195.88M
▲ 29.6% YoY
Diluted EPS
$0.32
Gross margin
84.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Inspire Medical Systems, Inc. Q1 FY2024 Earnings Call
Confident tone GLP-1 complementary positioning Direct-to-consumer and medical education Product innovation and pipeline
Revenue
$164.01M
▲ 28.2% YoY
Diluted EPS
$-0.34
Gross margin
84.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-06
Inspire Medical Systems, Inc. Q4 FY2023 Earnings Call
Confident tone Revenue growth and 2024 guidance GLP-1 and patient pipeline Operating income and profitability
Revenue
$192.51M*
▲ 39.6% YoY
Gross margin
85.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Inspire Medical Systems, Inc. Q3 FY2023 Earnings Call
Revenue
$153.30M
▲ 40.4% YoY
Diluted EPS
$-0.29
Gross margin
84.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-01
Inspire Medical Systems, Inc. Q2 FY2023 Earnings Call
Revenue
$151.09M
▲ 65.3% YoY
Diluted EPS
$-0.41
Gross margin
83.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-02
Inspire Medical Systems, Inc. Q1 FY2023 Earnings Call
Revenue
$127.90M
▲ 84.3% YoY
Diluted EPS
$-0.53
Gross margin
84.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-07
Inspire Medical Systems, Inc. Q4 FY2022 Earnings Call
Revenue
$137.90M*
▲ 75.9% YoY
Gross margin
83.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-01
Inspire Medical Systems, Inc. Q3 FY2022 Earnings Call
Revenue
$109.19M
▲ 77% YoY
Diluted EPS
$-0.60
Gross margin
81.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
Inspire Medical Systems, Inc. Q2 FY2022 Earnings Call
Revenue
$91.39M
▲ 72.6% YoY
Diluted EPS
$-0.53
Gross margin
84.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-03
Inspire Medical Systems, Inc. Q1 FY2022 Earnings Call
Revenue
$69.38M
▲ 71.9% YoY
Diluted EPS
$-0.61
Gross margin
85.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-18
Inspire Medical Systems, Inc. Q4 FY2021 Earnings Call
Revenue
$78.40M*
▲ 70.4% YoY
Gross margin
85.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-02
Inspire Medical Systems, Inc. Q3 FY2021 Earnings Call
Revenue
$61.69M
▲ 72.1% YoY
Diluted EPS
$-0.38
Gross margin
86.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-03
Inspire Medical Systems, Inc. Q2 FY2021 Earnings Call
Revenue
$52.96M
▲ 334.7% YoY
Diluted EPS
$-0.48
Gross margin
85.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Inspire Medical Systems, Inc. Q1 FY2021 Earnings Call
Revenue
$40.35M
▲ 89% YoY
Diluted EPS
$-0.60
Gross margin
85.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-23
Inspire Medical Systems, Inc. Q4 FY2020 Earnings Call
Revenue
$46.01M
▲ 71% YoY
Gross margin
84.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-02
Inspire Medical Systems, Inc. Q3 FY2020 Earnings Call
Revenue
$35.84M
▲ 71.8% YoY
Diluted EPS
$-0.39
Gross margin
85.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-04
Inspire Medical Systems, Inc. Q2 FY2020 Earnings Call
Revenue
$12.18M
▼ 32.4% YoY
Diluted EPS
$-0.88
Gross margin
84.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
Inspire Medical Systems, Inc. Q1 FY2020 Earnings Call
Revenue
$21.35M
▲ 31.4% YoY
Gross margin
84.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-25
Inspire Medical Systems, Inc. Q4 FY2019 Earnings Call
Revenue
$26.91M
▲ 62.5% YoY
Gross margin
84.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–27 of 27 earnings calls
Key facts CIK 1609550 CUSIP 457730109 13F (30d) 269 filings 254 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)